AstraZeneca's kidney disease drug recommended for EU approval
Shares in pharmaceutical giant AstraZeneca (AZN) rallied 1% to £85.77 on Monday after the company said its chronic kidney disease drug had been recommended for approval in the EU.The European Medicines Agency based its opinion on...
28 June 2021
